39 research outputs found
Assessment of Consistency of Fixed Airflow Obstruction Status during Budesonide/Formoterol Treatment and Its Effects on Treatment Outcomes in Patients with Asthma
BackgroundThe consistency of fixed airflow limitation status during treatment in patients with asthma is unknown.ObjectiveThe objective of this study was to determine the consistency of fixed airflow obstruction (FAO) status during treatment and effects on treatment response.MethodsThis post hoc analysis from a 12-week study (NCT00652002) assessed patients aged 12 years or more with moderate-to-severe asthma randomized to twice-daily budesonide/formoterol (BUD/FM) via pressurized metered-dose inhaler (pMDI) 320/9 μg, BUD pMDI 320 μg, FM 9 μg via dry-powder inhaler, or placebo. FAO status was assessed postbronchodilator at screening and after study drug administration at weeks 2, 6, and 12 via the forced expiratory volume in 1 second to forced vital capacity (FEV1/FVC) ratio < lower limit of normal (LLN) (FAO+) or ≥ LLN (FAO−). Patients with persistent FAO− and FAO+ retained their screening FAO status at all visits. Patients with inconsistent FAO changed categories at least once during the study. Assessments included early withdrawal due to predefined worsening asthma events (PAEs), lung function, and symptoms.ResultsOf 386 patients, 29% had persistent FAO+, 31% inconsistent FAO, and 40% persistent FAO−. PAEs were lowest in the FAO− group overall and with BUD/FM treatment in patients with FAO+ and inconsistent FAO. Baseline demographics and treatment responses of the inconsistent FAO group were most similar to the FAO+ group. The greatest improvements in asthma control days and use of rescue medications were seen with BUD/FM treatment, regardless of FAO status.ConclusionsApproximately one third of patients with moderate-to-severe asthma in this study had inconsistent FAO, and their treatment responses were most similar to patients with FAO+. Regardless of FAO status, patients treated with BUD/FM experienced the most improved treatment responses and fewest withdrawals due to PAEs
Precision Measurement of the Proton and Deuteron Spin Structure Functions g2 and Asymmetries A2
We have measured the spin structure functions g2p and g2d and the virtual
photon asymmetries A2p and A2d over the kinematic range 0.02 < x < 0.8 and 0.7
< Q^2 < 20 GeV^2 by scattering 29.1 and 32.3 GeV longitudinally polarized
electrons from transversely polarized NH3 and 6LiD targets. Our measured g2
approximately follows the twist-2 Wandzura-Wilczek calculation. The twist-3
reduced matrix elements d2p and d2n are less than two standard deviations from
zero. The data are inconsistent with the Burkhardt-Cottingham sum rule if there
is no pathological behavior as x->0. The Efremov-Leader-Teryaev integral is
consistent with zero within our measured kinematic range. The absolute value of
A2 is significantly smaller than the sqrt[R(1+A1)/2] limit.Comment: 12 pages, 4 figures, 2 table
Measurement of the Proton and Deuteron Spin Structure Functions g2 and Asymmetry A2
We have measured the spin structure functions g2p and g2d and the virtual
photon asymmetries A2p and A2d over the kinematic range 0.02 < x < 0.8 and 1.0
< Q^2 < 30(GeV/c)^2 by scattering 38.8 GeV longitudinally polarized electrons
from transversely polarized NH3 and 6LiD targets.The absolute value of A2 is
significantly smaller than the sqrt{R} positivity limit over the measured
range, while g2 is consistent with the twist-2 Wandzura-Wilczek calculation. We
obtain results for the twist-3 reduced matrix elements d2p, d2d and d2n. The
Burkhardt-Cottingham sum rule integral - int(g2(x)dx) is reported for the range
0.02 < x < 0.8.Comment: 12 pages, 4 figures, 1 tabl
Measurements of the -Dependence of the Proton and Neutron Spin Structure Functions g1p and g1n
The structure functions g1p and g1n have been measured over the range 0.014 <
x < 0.9 and 1 < Q2 < 40 GeV2 using deep-inelastic scattering of 48 GeV
longitudinally polarized electrons from polarized protons and deuterons. We
find that the Q2 dependence of g1p (g1n) at fixed x is very similar to that of
the spin-averaged structure function F1p (F1n). From a NLO QCD fit to all
available data we find at
Q2=5 GeV2, in agreement with the Bjorken sum rule prediction of 0.182 \pm
0.005.Comment: 17 pages, 3 figures. Submitted to Physics Letters
Inclusive hadron photoproduction from longitudinally polarized protons and deuterons.
We report measurements of the asymmetry A_parallel for inclusive hadron production on longitudinally polarized proton and deuteron targets by circularly polarized photons. The photons were produced via internal and external bremsstrahlung from an electron beam of 48.35 GeV. Asymmetries for both positive and negative signed hadrons, and a subset of identified pions, were measured in the momentum range 1
Measurements of the dependence of the proton and neutron spin structure functions and
he structure functions g1p and g1n have been measured over the range 0.014 < x < 0.9 and 1 < Q2 < 40 GeV2 using deep-inelastic scattering of 48 GeV longitudinally polarized electrons from polarized protons and deuterons. We find that the Q2 dependence of g1p (g1n) at fixed x is very similar to that of the spin-averaged structure function F1p (F1n). From a NLO QCD fit to all available data we find at Q2=5 GeV2, in agreement with the Bjorken sum rule prediction of 0.182 \pm 0.005
Measurement of the deuteron spin structure function for .
New measurements are reported on the deuteron spin structure function g_1^d. These results were obtained from deep inelastic scattering of 48.3 GeV electrons on polarized deuterons in the kinematic range 0.01 < x < 0.9 and 1 < Q^2 < 40 (GeV/c)^2. These are the first high dose electron scattering data obtained using lithium deuteride (6Li2H) as the target material. Extrapolations of the data were performed to obtain moments of g_1^d, including Gamma_1^d, and the net quark polarization Delta Sigma
ACUTE EFFECTS OF CALCITONIN-GENE-RELATED PEPTIDE ON RENAL HEMODYNAMICS AND RENIN AND ANGIOTENSIN-II SECRETION IN PATIENTS WITH RENAL-DISEASE
The renal haemodynamic effects and renin-angiotensin II response io calcitonin gene-related peptide (CGRP) infusion were assessed in 16 patients with moderate hypertension and renal insufficiency. CGRP lowered the systemic mean blood pressure by 13% and increased the heart rate by 25%; the glomerular filtration rate rose from 56 +/- 11 ml/min to 71 +/- 8 ml/min (p < 0.005), the renal plasma flow decreased from 369 +/- 19 ml/min to 342 +/- 25 ml/min (p < 0.002) and the filtration fraction increased from 15 +/- 0.2% to 20 +/- 0.2%. Plasma renin activity rose stepwise during the CGRP infusion from 1.28 +/- 0.5 ng/ml/h to 1.66 +/- 0.4 and 1.89 +/- 0.4 ng/ml/h (p < 0.001). Angiotensin II showed a marked increase after 10 min of infusion (91.6 +/- 47.00 pg/ml) (control value 6.01 +/- 3.09 pg/ml) and at the end (28.63 +/- 16.00 pg/ml) (p < 0.001). CGRP exerts an apparently favourable effect on renal function of patients with renal insufficiency, but the observed increase of glomerular filtration rate is obtained by an increase of intraglomerular pressure secondary to angiotensin II production